Its increased expression correlates with prostate cancer progression to castration-resistant disease [112] and it is essential for EGF-promoted cell migration and invasion, as well as for EMT markers expression [108], AKT and GSK3β phosphorylation induced by EGF, and consequently for β-catenin stabilization [107]. This evidence concerns the gene AKT1 and prostate cancer.